MORGAN STANLEY PLC/CALL/MERCK & CO./135/0.1/17.01.25 Share Price

Warrant

DE000MB71H91

Delayed Börse Stuttgart 06:07:09 08/07/2024 pm IST
0.46 EUR +9.52% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./135/0.1/17.01.25
Current month-28.81%
1 month-32.26%
Date Price Change
08/24/08 0.46 +9.52%
05/24/05 0.42 +5.00%
04/24/04 0.4 -9.09%
03/24/03 0.44 -12.00%
02/24/02 0.5 -9.09%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 06:07 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB71H9
ISINDE000MB71H91
Date issued 06/06/2023
Strike 135 $
Maturity 17/01/2025 (193 Days)
Parity 10 : 1
Emission price 0.7
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.94
Lowest since issue 0.098
Delta0.4x
Omega 9.934
Premium10.79x
Gearing24.82x
Moneyness 0.9367
Difference Strike 7.645 $
Difference Strike %+5.66%
Spread 0.02
Spread %4.17%
Theoretical value 0.4700
Implied Volatility 21.04 %
Total Loss Probability 65.29 %
Intrinsic value 0.000000
Present value 0.4700
Break even 140.09 €
Theta-0.01x
Vega0.03x
Rho0.02x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus